AzTrials
AzTrials

Hyperkyphosis, AdolescentNCT04924556

The Effect of Rıgıd Brace on Spinopelvic Parameters and GAP Score in Adolescents With Structural Hyperkyphosis

An observational study of Hyperkyphosis, Adolescent and Scheuermann Disease, run by Halic University at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aimed to investigate the effect of rıgıd brace treatment on spinopelvic parameters and GAP score in patients with adolescent hyperkyphosis. This was a retrospective analysis of prospectively collected data. Read more about this study

Who is it for?
Ages 10 to 18 years
How many people
40 participants
Where
1 siteTurkey (Türkiye)
Study dates
29 Mar 2021to 16 Aug 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: 10-18 years patients with Scheuermann's kyphosis or adolescent hyperkyphosis and treated with CAD-CAM design a rigid brace

Who may be able to join

  • Subjects who diagnosed with Scheuermann's kyphosis or adolescent hyperkyphosis.
  • Inıtial curve magnitude between 55-75°
  • Patients who followed up at least 6 months
  • Patients who wearing CAD-CAM (Computer-Aided Design\&Computer-Aided Manufacturing) design TLSO(Thoraco-lumbo-sacral orthosis) kyphosis brace in 16 hours/day or more

Who cannot join

  • History of spinal surgery or trauma
  • Patients has kyphosis due to congenital, neuromuscular, traumatic, tumor, infection causes
  • Ankylosing spondylitis and other spondyloarthropathies.
  • The lack of appropriate full-length lateral radiography with acceptable quality at the baseline or final assessment.

Trial locations and contacts

1 site in 1 country.

Ahsen Büyükaslan, PhD(c) contact

905336992960

ahsen.buyukaslan@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Formed Healthcare Scoliosis Treatment and Brace Center

    Istanbul, İ̇stanbul, 34384

    Ahsen Büyükaslan, MSc., 05336992960, ahsen.buyukaslan@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

This study aimed to investigate the effect of rıgıd brace treatment on spinopelvic parameters and GAP score in patients with adolescent hyperkyphosis. This was a retrospective analysis of prospectively collected data. Thirty-two patients who were diagnosed with structural hyperkyphosis and treated with CAD-CAM design rigid brace were included in the study in Formed Healthcare Scoliosis Treatment and Brace Center between December 2015-2020.

Keywords
Scheuermann Disease, Adolescent Hyperkyphosis, Sagittal Balance, Spinopelvic Parameters
Medical subject headings
Scheuermann Disease, Spinal Curvatures

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from kyphosis angle at 6 months

    Change from Baseline kyphosis angle(degree) in standing full-length lateral digital radiographs at 6 months. It will measure between T4-T12 vertebra.

    Measured: 6 months after from beginning of study

  2. Change from lordosis angle at 6 months

    Change from Baseline lordosis angle(degree) in standing full-length lateral digital radiographs at 6 months. It will measure from the L1-S1 and L4-S1 levels of the vertebra.

    Measured: 6 months after from beginning of study

  3. Change from the global tilt at 6 months

    Change from Baseline global tilt(degree) in standing full-length lateral digital radiographs at 6 months. The global tilt is the sum of the C7 vertical tilt and the pelvic tilt.

    Measured: 6 months after from beginning of study

  4. Change from Global Alignment and Proportion (GAP) score at 6 months

    GAP score is a new pelvic incidence-based proportional method to analyze sagittal alignment and balance, developed by the European Spine Study Group (ESSG). The GAP score evaluates the disproportion, magnitude and distribution of lumbar lordosis, and the global spinopelvic alignment proportionally rather than an absolute numerical value when compared to the ideal calculated for any individual. GAP score has five domains including relative pelvic version, relative lumbar lordosis, lordosis distribution index, relative spinopelvic alignment, and age factor. Scores of each of the four domains vary between 0 to 3 and age factor domain varies between 0 to 1. The total GAP score is between 0 and 13 points and obtained by adding the scores of these five domains. If the total score was 0 to 2, alignment accepted as proportional; 3 to 6 as moderate malalignment; ≥7 was accepted as severe malalignment.

    Measured: 6 months after from beginning

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jun 2021
  2. Study start29 Mar 2021
  3. Primary completion14 Jun 2021 (estimated)
  4. Study completion16 Aug 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04924556
Sponsor's protocol ID
HUEK-
Status last verified
Jun 2021
First submitted
26 May 2021
Last updated
14 Jun 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Hyperkyphosis, Adolescent and Scheuermann Disease, run by Halic University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ahsen Büyükaslan, PhD(c) (905336992960, ahsen.buyukaslan@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from kyphosis angle at 6 months (time frame: 6 months after from beginning of study). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jun 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in